HCA Healthcare, Inc. $HCA Shares Bought by Citizens Financial Group Inc. RI

Key Points

• Citizens Financial Group increased its stake in HCA Healthcare by 4% in Q4 to 66,718 shares worth about $31.15 million, and institutional investors now own roughly 62.73% of the company.
• HCA reported quarterly EPS of $7.15 (a $0.04 miss) on $19.11 billion in revenue, up 4.3% year‑over‑year, and reiterated FY2026 EPS guidance of 29.10–31.50 (analysts forecast ~30.05).
• The board declared a quarterly dividend of $0.78 ($3.12 annual, 0.7% yield; ex‑dividend June 16), while insiders sold about 15,214 shares (~$7.8M) recently; the stock carries a consensus Moderate Buy rating with a $520.55 target.

Citizens Financial Group Inc. RI increased its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 4.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 66,718 shares of the company's stock after buying an additional 2,592 shares during the quarter. Citizens Financial Group Inc. RI's holdings in HCA Healthcare were worth $31,148,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Palisade Asset Management LLC acquired a new stake in shares of HCA Healthcare in the 3rd quarter worth approximately $26,000. Holos Integrated Wealth LLC bought a new stake in HCA Healthcare during the fourth quarter worth approximately $29,000. Ares Financial Consulting LLC bought a new position in HCA Healthcare during the 4th quarter valued at $31,000. JPL Wealth Management LLC bought a new stake in shares of HCA Healthcare in the 3rd quarter worth $33,000. Finally, Aventura Private Wealth LLC bought a new position in HCA Healthcare during the fourth quarter valued at about $34,000. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Trading Up 0.1%

NYSE:HCA opened at $435.01 on Friday. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52. The business's fifty day moving average price is $497.66 and its 200 day moving average price is $485.41. The firm has a market capitalization of $96.78 billion, a price-to-earnings ratio of 14.96, a PEG ratio of 1.38 and a beta of 1.36.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts' consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. HCA Healthcare's revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts forecast that HCA Healthcare, Inc. will post 30.05 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare's payout ratio is currently 10.73%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. TD Cowen cut their price target on shares of HCA Healthcare from $561.00 to $500.00 and set a "buy" rating for the company in a report on Monday. The Goldman Sachs Group raised their target price on shares of HCA Healthcare from $520.00 to $558.00 and gave the stock a "buy" rating in a report on Wednesday, January 28th. Truist Financial dropped their price target on HCA Healthcare from $546.00 to $535.00 and set a "buy" rating on the stock in a report on Monday. Wall Street Zen cut HCA Healthcare from a "strong-buy" rating to a "buy" rating in a report on Saturday, February 14th. Finally, Argus upped their target price on HCA Healthcare from $530.00 to $560.00 and gave the company a "buy" rating in a report on Friday, February 6th. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $520.55.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 1,500 shares of the business's stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total value of $747,135.00. Following the completion of the sale, the executive vice president owned 30,003 shares of the company's stock, valued at approximately $14,944,194.27. The trade was a 4.76% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Jennifer Berres sold 8,020 shares of the firm's stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the transaction, the senior vice president directly owned 11,993 shares in the company, valued at approximately $6,171,357.94. The trade was a 40.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 15,214 shares of company stock valued at $7,797,595 in the last three months. 1.50% of the stock is currently owned by insiders.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA plans a major expansion at its Kendall (Miami‑Dade) hospital, signaling revenue/capacity growth in a key market and supporting longer‑term organic growth prospects. HCA Florida Kendall Hospital Plans Expansion
• Positive Sentiment: HCA will present at the RBC Global Healthcare Conference on May 20 — an opportunity to reinforce its FY2026 guidance (EPS range reiterated) and highlight execution plans to investors. Increased investor visibility can support multiple expansion or valuation reassessment. HCA Healthcare to Present at May Conference
• Neutral Sentiment: Quarterly results showed $19.1B in revenue (up ~4.3% y/y) but a slight EPS miss; management maintained FY26 EPS guidance. Revenue growth is encouraging but the EPS miss and operational headwinds (storm impacts, lower ER volumes) make this a mixed read for near‑term earnings momentum. HCA Posts $19.1B in Revenue
• Neutral Sentiment: Multiple local executive moves (COO hires/transfers in Missouri, California and a Florida CEO moving to Virginia) are routine for a large system and unlikely to move the stock materially, though they reflect ongoing operational re‑shuffles. HCA Missouri Hospital Taps New COO HCA Florida CEO Transitions CEO Responses to Lawmaker Comments
• Neutral Sentiment: Sector/idea pieces (e.g., Zacks highlighting medical stocks) may draw fresh buyer interest into healthcare names including HCA, but these are general flows rather than HCA‑specific catalysts. Zacks: Two Medical Stocks
• Negative Sentiment: Analyst action: a published target cut (Yahoo Finance coverage) pressures valuation and can weigh on sentiment, even if the firm still credits HCA’s operational execution. Investor reaction to lowered price targets can be downward. HCA: A Target Cut
• Negative Sentiment: HCA confirmed layoffs — a near‑term negative headline that may reflect margin pressure and restructuring; while cost cuts can help margins later, layoffs often create short‑term investor uncertainty. HCA Confirms Layoffs
• Negative Sentiment: Ongoing regulatory and public scrutiny (examples: lawmakers’ comments on hospital profitability and regional competition/appeals in local markets) could increase reputational or policy risk over time. AdventHealth/UNC Appeal Decision

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.